AstraZeneca's chances of remaining independent boosted as it unveils raft of positive data from cancer drug pipeline

June 4, 2014 12:33 AM

6 0

AstraZeneca's chances of remaining independent boosted as it unveils raft of positive data from cancer drug pipeline

AstraZeneca's chances of remaining independent were boosted as it unveiled a raft of positive data from its cancer drug pipeline, reinforcing the key plank of boss Pascal Soriot’s defence against US predator Pfizer.

AstraZeneca's chances of remaining independent were boosted as it unveiled a raft of positive data from its cancer drug pipeline, reinforcing the key plank of boss Pascal Soriot’s defence against US predator Pfizer.

Read more

To category page

Loading...